Evidence map›Paper›PMID 37288288›Full record

ArticleInfectious Disease Modelling2023

Understanding the impact of disease and vaccine mechanisms on the importance of optimal vaccine allocation.

Isobel R Abell, James M McCaw, Christopher M Baker

Open access · goldAbstract read
In one paragraph

Article in Infectious Disease Modelling, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Isobel R AbellSchool of Mathematics and Statistics, The University of Melbourne, Melbourne, Australia.
James M McCawSchool of Mathematics and Statistics, The University of Melbourne, Melbourne, Australia.
Christopher M BakerSchool of Mathematics and Statistics, The University of Melbourne, Melbourne, Australia.
The University of Melbourne · AUThe Royal Melbourne Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vaccination is an important epidemic intervention strategy. However, it is generally unclear how the outcomes of different vaccine strategies change depending on population characteristics, vaccine mechanisms and allocation objective. In this paper we develop a conceptual mathematical model to simulate strategies for pre-epidemic vaccination. We extend the SEIR model to incorporate a range of vaccine mechanisms and disease characteristics. We then compare the outcomes of optimal and suboptimal vaccination strategies for three public health objectives (total infections, total symptomatic infections and total deaths) using numerical optimisation. Our comparison shows that the difference in outcomes between vaccinating optimally and suboptimally depends on vaccine mechanisms, disease characteristics, and objective considered. Our modelling finds vaccines that impact transmission produce better outcomes as transmission is reduced for all strategies. For vaccines that impact the likelihood of symptomatic disease or dying due to infection, the improvement in outcome as we decrease these variables is dependent on the strategy implemented. Through a principled model-based process, this work highlights the importance of designing effective vaccine allocation strategies. We conclude that efficient allocation of resources can be just as crucial to the success of a vaccination strategy as the vaccine effectiveness and/or amount of vaccines available.

Indexed as

EpidemiologyMathematical modelling

Identifiers

PMID37288288
PMCPMC10241858
OpenAlexW4377289147

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.